239 related articles for article (PubMed ID: 18379535)
21. Icodextrin dialysate improves nutritional and inflammatory profiles in peritoneal dialysis patients.
Lin W; Chen YC; Wu MS; Hsu HJ; Sun CY; Lin YK; Wu IW
Ren Fail; 2009; 31(2):98-105. PubMed ID: 19212905
[TBL] [Abstract][Full Text] [Related]
22. Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis.
Babazono T; Nakamoto H; Kasai K; Kuriyama S; Sugimoto T; Nakayama M; Hamada C; Furuya R; Hasegawa H; Kasahara M; Moriishi M; Tomo T; Miyazaki M; Sato M; Yorioka N; Kawaguchi Y;
Am J Nephrol; 2007; 27(4):409-15. PubMed ID: 17622748
[TBL] [Abstract][Full Text] [Related]
23. Ten years after MIDAS: icodextrin lights and shadows.
Amici G; Da Rin G; Agostini A; Velo S; Bocci C
Contrib Nephrol; 2003; (140):76-81. PubMed ID: 12800346
[No Abstract] [Full Text] [Related]
24. Significant intra- and interpatient variation in ultrafiltration achieved by icodextrin in APD patients.
Liakopoulos V; Zarogiannis S; Eleftheriadis T; Dovas S; Stefanidis I
Perit Dial Int; 2007; 27(1):97-8. PubMed ID: 17179521
[No Abstract] [Full Text] [Related]
25. Evidence-based medicine in peritoneal dialysis: peritoneal dialysis solutions.
Feriani M
Contrib Nephrol; 2003; (140):202-8. PubMed ID: 12800361
[No Abstract] [Full Text] [Related]
26. [Effect of using icodextrin as a starting therapy for peritoneal permeability].
Fernández-Reyes MJ; Bajo MA; del Peso G; Olea T; Sánchez-Villanueva RL; González E; Heras M; Sánchez R; Selgas R
Nefrologia; 2009; 29(2):130-5. PubMed ID: 19396318
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of peritoneal dialysis with icodextrin in the long-term treatment of refractory congestive heart failure.
Basile C; Chimienti D; Bruno A; Cocola S; Libutti P; Teutonico A; Cazzato F
Perit Dial Int; 2009; 29(1):116-8. PubMed ID: 19164263
[No Abstract] [Full Text] [Related]
28. Peritoneal accumulation of advanced glycosylation end-products in diabetic rats on dialysis with icodextrin.
Lee JH; Reddy DK; Saran R; Moore HL; Twardowski ZJ; Nolph KD; Khanna R
Perit Dial Int; 2000; 20 Suppl 5():S39-47. PubMed ID: 11229611
[TBL] [Abstract][Full Text] [Related]
29. The effect of icodextrin and glucose-containing solutions on insulin resistance in CAPD patients.
Gürsu EM; Ozdemir A; Yalinbas B; Gürsu RU; Canbakan M; Güven B; Atasoyu EM; Keskin AT; Elçi A; Baru Y
Clin Nephrol; 2006 Oct; 66(4):263-8. PubMed ID: 17063993
[TBL] [Abstract][Full Text] [Related]
30. Effect of Icodextrin Solution on the Preservation of Residual Renal Function in Peritoneal Dialysis Patients: A Randomized Controlled Study.
Chang TI; Ryu DR; Yoo TH; Kim HJ; Kang EW; Kim H; Chang JH; Kim DK; Moon SJ; Yoon SY; Han SH;
Medicine (Baltimore); 2016 Mar; 95(13):e2991. PubMed ID: 27043667
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal relationships between fluid status, inflammation, urine volume and plasma metabolites of icodextrin in patients randomized to glucose or icodextrin for the long exchange.
Davies SJ; Garcia Lopez E; Woodrow G; Donovan K; Plum J; Williams P; Johansson AC; Bosselmann HP; Heimburger O; Simonsen O; Davenport A; Lindholm B; Tranaeus A; Divino Filho JC
Nephrol Dial Transplant; 2008 Sep; 23(9):2982-8. PubMed ID: 18456678
[TBL] [Abstract][Full Text] [Related]
32. Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients.
Moriishi M; Kawanishi H; Tsuchiya S
Adv Perit Dial; 2006; 22():24-8. PubMed ID: 16983933
[TBL] [Abstract][Full Text] [Related]
33. Effects of icodextrin on insulin resistance and adipocytokine profiles in patients on peritoneal dialysis.
Takeguchi F; Nakayama M; Nakao T
Ther Apher Dial; 2008 Jun; 12(3):243-9. PubMed ID: 18503703
[TBL] [Abstract][Full Text] [Related]
34. Effects of icodextrin on patient survival and technique success in patients undergoing peritoneal dialysis.
Han SH; Ahn SV; Yun JY; Tranaeus A; Han DS
Nephrol Dial Transplant; 2012 May; 27(5):2044-50. PubMed ID: 21968011
[TBL] [Abstract][Full Text] [Related]
35. Use of new peritoneal dialysis solutions in children.
Canepa A; Verrina E; Perfumo F
Kidney Int Suppl; 2008 Apr; (108):S137-44. PubMed ID: 18379537
[TBL] [Abstract][Full Text] [Related]
36. Effects of icodextrin peritoneal dialysis solution on the peritoneal membrane in the STZ-induced diabetic rat model with partial nephrectomy.
Nakao A; Nakao K; Takatori Y; Kojo S; Inoue J; Akagi S; Sugiyama H; Wada J; Makino H
Nephrol Dial Transplant; 2010 May; 25(5):1479-88. PubMed ID: 19759273
[TBL] [Abstract][Full Text] [Related]
37. [Icodextrin: What arguments for and against its use as an osmotic agent in peritoneal dialysis].
Savenkoff B; Flechon-Meibody F; Goffin É
Nephrol Ther; 2018 Jun; 14(4):201-206. PubMed ID: 29291942
[TBL] [Abstract][Full Text] [Related]
38. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
Ueda Y; Miyata T; Goffin E; Yoshino A; Inagi R; Ishibashi Y; Izuhara Y; Saito A; Kurokawa K; Van Ypersele De Strihou C
Kidney Int; 2000 Dec; 58(6):2518-24. PubMed ID: 11115086
[TBL] [Abstract][Full Text] [Related]
39. The effect of icodextrin-based solutions on peritoneal transport in rats undergoing chronic peritoneal dialysis.
Pawlaczyk K; Garcia-Lopez E; Kuzlan-Pawlaczyk M; Heimbürger O; Bergström J; Breborowicz A; Lindholm B
Perit Dial Int; 2001; 21 Suppl 3():S359-61. PubMed ID: 11887855
[TBL] [Abstract][Full Text] [Related]
40. Falsely Elevated Glucose Concentrations in Peritoneal Dialysis Patients Using Icodextrin.
Dogan K; Kayalp D; Ceylan G; Azak A; Senes M; Duranay M; Yucel D
J Clin Lab Anal; 2016 Sep; 30(5):506-9. PubMed ID: 26511081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
